"Your life is waiting!": Symbolic meanings in direct-to-consumer antidepressant advertising

Journal of Communication Inquiry

Volumn 30, Issue 2, 2006, Pages 163-188

  Grow, Jean M ^a   Park, Jin Seong ^b   Han, Xiaoqi ^a  

^a MARQUETTE UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Antidepressants; Depression; DTC advertising; Pharmaceuticals; Regulation

Indexed keywords

EID: 34548826713     PISSN: 01968599     EISSN: 15524612     Source Type: Journal    
DOI: 10.1177/0196859905285315     Document Type: Article

References (57)

1. Altshuler, L. L., Hendrick, V., & Burt, V. K. (1998). Mood disorders. In L. A. Wallis (Ed.), Textbook of women's health (pp. 809-818). Philadelphia: Lippincott-Raven Publishers.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: American Psychiatric Association.
3. Barthes, R. (1977). Elements of semiology (Reissue ed.). New York: Hill and Wang.
4. Bell, R. A., Wilkes, M. S., & Kravitz, R. L. (2000). The educational value of consumer-targeted prescription drug print advertising. Journal of Family Practice, 49(12), 1092-1098.
5. Bowie, M. (2001). Barthes of Proust. Yale Journal of Criticism, 14(2), 513-518.
6. Calfee, J. E. (2002). Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy and Marketing, 21(Fall), 174-193.
7. Carmen, E. H., Russo, N. F., & Miller, J. B. (1981). Inequality and women's mental health: An overview. American Journal of Psychiatry, 138, 1319-1330.
8. Copeland, M. B. (2001). The relationship among psychiatrists' attitudes toward women and diagnoses and willingness to prescribe anti-depressant medication (Doctoral dissertation, Columbia University, 2001). Dissertation Abstracts International, 62, B4777.
9. Courtney, K. (2003). BBDO Worldwide enters the lucrative category of marketing prescription drugs to consumers. Retrieved August 2005, from www.maryfurlong.com/index.php/articles/news/8
10. Creed, W. E. D., Langstraat, J. A., & Scully, M. A. (2002). A picture of the frame: Frame analysis as technique and as politics. Organizational Research Methods, 5(1), 34-55.
11. Davis, J. J. (2000). Riskier than we think? The relationship between risk statement completeness and perceptions of direct consumer advertised prescription drugs. Journal of Health Communication, 5(4), 349-369.
12. de Saussure, F. (1998). Course in general linguistics. In W McNeil & K. S. Feldman (Eds.), Continental philosophy: An anthology (pp. 294-304). Malden, MA: Blackwell.
13. Eco, U. (1984). Semiotics and the philosophy of language. Bloomington: Indiana University Press.
14. Entman, R. M. (1991). Framing U. S. coverage of international news: Contrasts in narratives of the KAL and Iran Air incidents. Journal of Communication, 41(4), 6-26.
15. Fiske, J. (1990). Introduction to communication studies. New York: Routledge.
16. Foote, S. M., & Etheredge, L. (2000). Increasing use of new prescription drugs: A case study. Health Affairs, 19(4), 165-170.
17. Freden, L. (1982). Psychosocial aspects of depression: No way out? New York: John Wiley.
18. Gamson, W. (1992). Talking politics. New York: Cambridge University Press.
19. Gardner, P. M. (2001). Recovery culture: The promotion of depression and consumption of mental health technologies in contemporary social practices. (Doctoral dissertation, University of Massachusetts, Amherst, 2001). Dissertation Abstracts International, 62, 1258A.
20. Gitlin, T. (1980). The whole world is watching. Berkeley: University of California Press.
21. Goldman, R., & Montagne, M. (1986). Marketing "mind mechanics": Decoding antidepressant drug advertising. Social Science and Medicine, 22, 1047-1058.
22. Hansen, F. J., & Dawn, O. (1995). Portrayal of women and elderly patients in psychotropic drug advertisements. Women and Therapy, 16(1), 129-141.
23. Hollon, M. F. (2005). Direct-to-consumer advertising: A haphazard approach to health promotion [Editorial]. Journal of the American Medical Association, 293(16), 2030-2033.
24. Holtz, W. E. (1998). Consumer-directed prescription drug advertising: Effects on public health. Journal of Law and Health, 139(2), 199-218.
25. Huh, J., Delorme, D. E., & Reid, L. N. (2004). The information utility for DTC prescription drug advertising. Journalism and Mass Communication Quarterly, 81(4), 788-806.
26. IMS Health Inc. (1998, September 15). Majority of physicians have negative view toward DTC advertising [Press release]. Fairfield, CT: Author.
27. Kessler, D. A., & Pines, W. L. (1990). The federal regulation of prescription drug advertising and promotion. Journal of the American Medical Association, 264(18), 2409-2415.
28. Kotulak, R. (2002, January 9). Drugs spur big rise in depression treatment. Knight-Ridder Tribune Business News, p. A1.
29. Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., et al. (2005). Influence of patients' requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. Journal of the American Medical Association, 293(16), 1995-2002.
30. Lexchin, J., & Mintzes, B. (2002). Direct-to-consumer advertising of prescription drugs: The evidence says no. Journal of Public Policy and Marketing, 21(2), 194-201.
31. Lindlof, T. R., & Taylor, B. C. (2002). Qualitative communication research methods (2nd ed.). Thousand Oaks, CA: Sage.
32. Lõvdahl, U., Riska, A., & Riska, E. (1999). Gender display in Scandinavian and American advertising for anti-depressants. Scandinavian Journal of Public Health, 27, 306-310.
33. The Mayo Clinic. (2005). Mental illness and stigma: Coping with the ridicule. Retrieved August 13, 2005, from http://edition.cnn.com/HEALTH/library/ MH/00076.html
34. MediaMark. (2002). Retrieved November 2002, from http://marquette.edu/ library/research/descriptions/mediamark.html
35. Mehta, A., & Purvis, S. C. (2003). Consumer response to print prescription drug advertising. Journal of Advertising Research, 43, 194-206.
36. Nadelson, C. C., & Dickstein, L. J. (1998). The mental health of women: An overview. In L. A. Wallis (Ed.), Textbook of women's health (pp. 783-788). Philadelphia: Lippincott-Raven Publishers.
37. The new face of consumer advertising: 11th annual report on DTC. (2005, June). MedAdNews, 24(6), 1.
38. Parker, B. J., & Delene, L. M. (1998). Direct-to-consumer prescription drug advertising: Content analysis and public policy implications. Journal of Pharmaceutical Marketing and Management, 1294, 27-42.
39. Paul, D. P., Handlin, A., & Stanton, A. D. (2002). Primary care physicians' attitudes toward direct-to-consumer advertising of prescription drugs: Still crazy after all these years. Journal of Consumer Marketing: Santa Barbara, 19(7), 564-574.
40. Peirce, C. S., Hartshorne, C., Weiss, P., & Burks, A. W. (1994). The collected papers of Charles Sanders Peirce. Charlottesville, VA: InteLex Corporation.
41. Pinto, M. B., Pinto, J. K., & Barber, J. C. (1998). The impact of pharmaceutical direct advertising. Health Marketing Quarterly, 15(4), 89-101.
42. Rosenthal, M. B., Berndt, E. R., Donohue, J. M., Frank, R. G., & Epstein, A. M. (2002). Promotion of prescription drugs to consumers. New England Journal of Medicine, 346(7), 498-505.
43. Scheufele, D. A. (1999). Framing as a theory of media effects. Journal of Communication, 49, 103-122.
44. Schwandt, T. A. (2001). Dictionary of qualitative inquiry (2nd ed.). Thousand Oaks, CA: Sage.
45. Schwartz, T.T. (1973). The responsive chord. Garden City, NY: Anchor/Doubleday.
46. Stimson, S. (1975). The message of psychotropic drug ads. Journal of Communication, 25(3), 153-160.
47. Stoppard, J. M. (2000). Understanding depression: Feminist social constructionist approaches. New York: Routledge.
48. Sturrock, J. (1979). Structuralism and since: From Lévi-Strauss to Derrida. Oxford, U.K. & New York: Oxford University Press.
49. Sylvain, M. (2005). The double-edged sword of consumer drug ads. Medical Post, 41(18), p. 1.
50. Thomaselli, R. (2005, August 2). Pharmaceutical industry issues DTC ad guidelines: Softball approach rejects calls for restrictions or moratorium. Retrieved August 13, 2005, from www.adage.com/paypoints/buyArticle.cms/login? newsID=45698&auth=
51. The tipping point: Pharmaceutical marketers have to start building consumer loyalty. (2003, June). Med Ad News, 24(6), p. 1.
52. Valenstein, E. S. (1998). Blaming the brain: The truth about drugs and mental health. New York: Free Press.
53. Vatjanapukka, V., & Waryszak, R. (2004). Relationship between consumer knowledge, prescription drug advertising exposure and attitudes towards direct-to-consumer prescription drug advertising. International Journal of Medical Marketing, 4(4), 350-360.
54. Vedantam, S. (2002, January 9). Report shows big rise in treatment for depression. Washington Post, p. A1.
55. Weiss, G. L., & Lonnquist, L. E. (1997). The sociology of health, healing, and illness. Upper Saddle River, NJ: Prentice Hall.
56. Wilkes, M. S., Doblin, B. S., & Shapiro, M. F. (1992). Pharmaceutical advertisements in leading medical journals: Experts' assessments. Annals of Internal Medicine, 116, 912-919.
57. Wilkes, M. S., Bell, R. A., & Kravitz, R. L. (2000). Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Affairs, 19, 110-128.